BackCollPlant Biotechnologies Overview

CollPlant Biotechnologies Receivables

CollPlant Biotechnologies's receivables is $230K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$233000.00
↓ 47.05% YoYΔ $-207000.00 vs prior year quarter

Peer trimmed avg / median

Loading

CollPlant Biotechnologies Receivables History

Loading

CollPlant Biotechnologies vs. peers: Receivables Comparison

Loading

CollPlant Biotechnologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CollPlant Biotechnologies (CLGN) FAQ

As of the most recent data (March 2026), CLGN shows a receivables of $230K. That compares with $440K in the prior-year period — down 47.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLGN's receivables is now $230K (was $440K) — a 47.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CollPlant Biotechnologies is outperforming or lagging.

Tracking CLGN's receivables over time shows whether CollPlant Biotechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $230K That compares with $440K in the prior-year period — down 47.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has CollPlant Biotechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $230K) with ownership activity and broader fundamentals.

CollPlant Biotechnologies's receivables is $230K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.